Endurant Capital Management LP Maravai Lifesciences Holdings, Inc. Transaction History

Endurant Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $9,157 - $11,618	-705 Reduced 3.29%	20,753 $290,000
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $15,637 - $30,999	-1,251 Reduced 5.51%	21,458 $307,000
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $6,303 - $9,293	-306 Reduced 1.33%	22,709 $580,000
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $599,540 - $862,602	23,015 New	23,015 $654,000
Q4 2021 Feb 14, 2022	SELL	$35.0 - $45.94 $1.04 Million - $1.37 Million	-29,838 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $1.1 Million - $1.81 Million	29,838 New	29,838 $1.46 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $1.89 Million - $2.62 Million	-58,168 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.8 - $38.49 $1.5 Million - $2.24 Million	58,168 New	58,168 $2.07 Million

227

140M

237K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $650M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.